Frequency of Metabolic Syndrome in Patients With Ischemic Stroke
DOI:
https://doi.org/10.54112/bcsrj.v6i4.1697Keywords:
Frequency; Metabolic syndrome: ischemic strokeAbstract
Stroke is the second-leading cause of mortality globally and metabolic syndrome is considered a distinct risk factor for stroke. Objective: The aim this study was to determine the frequency of metabolic syndrome in patients with ischemic stroke. Method: The current cross-sectional study was conducted in Qazi Hussain Ahmad Medical Complex, Nowshera, over 6 months after taking approval from the CPSP and ethical board of the institute from 2nd July 2024 to 2nd January 2025. A total of 145 individuals of both gender and different age groups (30-70 years) diagnosed with ischemic stroke were included. Demographic features such as age, gender, occupation, BMI socio economic status, smoking history and residency were recorded. Individuals with ischemic stroke were examine for metabolic syndrome which were labeled positive based on the 3 criteria that are triglycerids level ≥ 150mg/dl, HDL level ≤ 40mg/dl in males and ≤ 50mg/ dl in females ,hypertension (blood pressure ≥ 130/85) and diabetes Fasting blood glucose ≥ 126mg/d. Data was analyzed through SPSS version 21.0. The Shapiro-Wilk test was used to determine the uniformity of the continuous data. Ages, height, weight, body mass index & the duration of acute ischemic stroke were calculated using mean, SD, or median (with IQR). Chi-square and Fisher exact tests were employed to assess the significance of study parameter proportions across courses. A p-value less than 0.05 was regarded as statistically significant. Results: A total of 145 individuals with ischemic heart disease were enrolled in this study out of which 102(70.3%) were male and 43(29.6%) were females. Metabolic syndrome was identified in 72(50%) individuals. Gender significantly correlates with metabolic syndrome (P < 0.05). The mean triglyceride level was 1151.36±17.8 mg/dL, HDL level was 45.6±5.9 mg/dL and fasting blood glucose level was 118.6 ± 38.4 mg/dL. The most common components were hypertension and low HDL, which were positive in 85 (58.6%), followed by diabetes & elevated triglycerides levels in 66 (45.5%) and 58 (40%). Conclusion: Our study concluded that metabolic syndrome is a major risk factor for ischemic stroke.
Downloads
References
Matsuzawa Y. Metabolic syndrome – definition and diagnostic criteria in Japan. J. Atheroscler. Thromb. 2005; 12: 301
WHO, Technical Report Series 2016; 469.
Robert H Eckel. The Metabolic Syndrome. 17th ed. Chapter 236. In: Harrison’s Principles of Internal Medicine, Fauci,Braunwald, Kasper, Hongo, Jameson, Loscalzo, eds. NewYork: McGraw-Hill; 2018. pp. 1509-14.
Ford EA, Giles WH. A comparison of the prevalence of the metabolic syndrome using Two Proposed Definitions.Diabetes Care 2013; 26:575-81.
Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 2014;37(12):1595–607.
Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. 2008 Jan;39(1):30-5.
Simon Cronin, Peter J Kelly. Stroke and the MetabolicSyndrome in Populations: The Challenge Ahead. Stroke 2019; 40:3-4.
Hendryx M., Zullig K. J. Higher coronary heart disease and heart attack morbidity in Appalachian coal mining regions. Prev Med. 2009; 49(5): 355-359
Alberti M., Eckel R. H., Grundy S. M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; An international association for the study of obesity. Circulation. 2009; 120(16): 1640–1645
International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome, http://www.idf.org/metabolicsyndrome.
Gorter PM, Olijhoek JK, van-der-Graaf Y, Algra A, Rabelink TJ, Visseren FL. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004; 173(2):363-9
Koren-Morag N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke. 2005;36(7):1366-71
De Silva DA, Woon FP, Xie XY, Li Hsian Chen C, Chang HM, Wong MC. Metabolic syndrome among ethnic South Asian patients with ischemic stroke and comparison with ethnic Chinese patients: the Singapore General Hospital experience. J Stroke Cerebrovasc Dis. 2007; 16(3):119-21
Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med. 2006;166(1):106-11
Rincon F, Sacco RL, Kranwinkel G, Xu Q, Paik MC, BodenAlbala B, Elkind MS. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Dis. 2009; 28(1):65-71
Lindenstrøm E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ. 1994; 309(6946):11-5
McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, et al. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. J Am Geriatr Soc. 2006; 54(9):1317-24.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Naeem Khan, . Shehzad, Muhammad Bilal, Abdul Hanan, Aamir Khan, . Yasir

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.